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A survey to identify barriers in the public health role of community 
pharmacists 
 
Abstract 
Objectives 
This survey seeks the opinion of UK community pharmacists to identify barriers in the public 
health role of community pharmacists. 
 
Methods 
This study took the form of a descriptive, cross-sectional survey that generated mostly 
quantitative data. Questionnaires were mailed to 524 randomly selected community 
pharmacists from Barnet, London and its surrounding areas, Bedfordshire, Cardiff and 
Edinburgh. All statistical analyses were performed using the Statistical Package for the Social 
Sciences (SPSS 19.0). 
Key findings 
A majority of the respondents identified time pressure and workload (89.7%, C.I. ±4.94); lack 
of patients' records (78.6%, C.I. ±6.66); insufficient funding from the government (75.2%, C.I. 
±7.01); lack of understanding by healthcare providers of the training and skill sets of 
pharmacists (73.7%, C.I. ±7.25); and lack of understanding by the public of the training and 
skill sets of pharmacists (72.7%, C.I. ±7.29), as the main barriers in enhancing the public 
health role of community pharmacists in the UK. Male respondents were more likely to 
agree that 'insufficient funding' was a barrier (p = .006; Eta, η2 = .053). There was a negative 
correlation between 'age of respondents' and respondents agreeing that pharmacists should 
develop their own expertise in public health [ρ = -.185; p = .029]. Free text comments also 
highlighted a number of barriers, which included, among other things, time pressure and 
workload, commercial pressure from employers, lack of collaboration between healthcare 
professionals, and inadequate funding. 
Conclusions 
Several barriers associated with the public health role of community pharmacists have been 
identified as hindering the enhancement of this role. To enable the profession to evolve 
fully from product-oriented services to patient-centred care, many of these barriers will 
need to be tackled.  
 
Introduction 
A number of UK studies have confirmed the role of pharmacists in public health.1-6 However, 
a number of studies have also identified barriers hindering the public health role of 
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community pharmacists. These include: time pressure and workload;4,7-10 the training of 
pharmacists and their staff;4,10,11,12 and inadequate remuneration and lack of support from 
stakeholders.4,9,10,11,13 At the same time, safety concerns10,14 and lack of 
documentation10,15,16 have also been recognised as barriers hindering the provision of public 
health services from community pharmacies. 
 
However, as many of the identified barriers have originated from studies that were 
conducted overseas, some of their findings may not be generalisable to the UK. This survey 
seeks the opinion of UK community pharmacists to identify barriers hindering the public 
health role of community pharmacists in the UK. 
 
Methods 
This study was approved by the programme approval panel (PAP) and research ethics sub-
committee (RESC) of the University and took the form of a descriptive, cross-sectional 
survey that generated mostly quantitative data. Items were selected and included in the 
questionnaire based on the identified themes in the review of literature and information,10 
with assistance from J.O. and J.P. (content or face validity).17 The questionnaire was 
designed to take approximately 20 minutes to complete, with assurance of the 
confidentiality of the responses. The questionnaire was pilot tested for content, clarity and 
format of the questions on a group of 150 randomly selected community pharmacists in 
Bedfordshire area, England, as listed on the NHS Choices website.18 The purpose of the 
study was explained, with the response rate for the pilot study being 39% (59/150), after 
two reminders (three weeks apart). The Cronbach’s alpha was also calculated to estimate 
the internal consistency of the pilot survey questionnaire. Based on the 56 items tested on 
the pilot questionnaire, the SPSS reliability test indicated that the Cronbach's alpha was 
0.787. As this number (0.787) was greater than 0.7, there was no need to alter the 
questionnaire.19  
 
The questionnaire was designed to collect the demographic characteristics of the 
respondents, such as gender, age, and years of post-qualification experience.20 The 
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respondents were also requested to give their opinions on the perceived barriers to 
enhancing the public health role of community pharmacists in the UK, using a scale of 1-5 (1 
= disagree, 2 = strongly disagree, 3 = neither agree nor disagree, 4 = agree, 5 = strongly 
agree).20 J.O. and J.P. approved the questionnaire before its use. For the main study, the 
questionnaires were mailed with covering letters to 385 randomly selected community 
pharmacists from Barnet, London, and its surrounding areas, Cardiff and Edinburgh. The 
covering letter introduced the researchers, summarised the purpose of the study and 
guaranteed confidentiality. Two reminders were sent at three-week intervals to non-
responders to enhance the response rate. All statistical analyses were performed using the 
most recent version of the Statistical Package for the Social Sciences (SPSS 19.0).  
Results  
Eighty-eight usable responses were collected in the main survey, representing a response 
rate of 22.8% [88/385]. However, when these were combined with the returned pilot 
questionnaires (59) [59/150], the combined response rate for all questionnaires received 
became 28.05% (147/524).  
Pharmacists’ characteristics 
Both men (73 [50%]), and women (73) responded to the survey, C.I. ±8.09. Their age-range 
distribution is shown in Figure 1, which indicates that the youngest, as well as highest 
number of respondents, were aged between 20-29 years (26.5%, C.I. ±7.12), while the 
oldest, as well as the fewest number of respondents, were aged between 70-79 years (2.0%, 
C.I. ±2.26). The role distribution of the respondents (Figure 2) indicated that a majority of 
the respondents were working as employee community pharmacists (76.9%, C.I. ±6.8).  
 
Survey responses   
Barriers to the public health role of the community pharmacist 
In terms of the barriers to enhancing the public health role of community pharmacists in the 
UK [see Table 1], the majority of the respondents identified insufficient training of 
pharmacists in public health (66.5%, C.I. ±7.64); the lack of professional autonomy for 
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pharmacists (66.9%, C.I. ±7.64); the lack of input from public health practitioners (68.9%, C.I. 
±7.52); the lack of support from public health practitioners (69.3%, C.I. ±7.54); and difficulty 
in communicating with other public health providers (69.5%, C.I. ±7.5) as barriers.  
 
As well as the aforesaid, the majority of respondents also identified the lack of support from 
GPs (68.2%, C.I. ±7.56); insufficient funding from the government (75.2%, C.I. ±7.01); time 
pressure and workload (89.7%, C.I. ±4.94); the lack of patients' records (78.6%, C.I. ±6.66); 
the lack of instrumentation (55.9%, C.I. ±8.06); the lack of understanding by the public of 
the training and skill sets of pharmacists (72.7%, C.I. ±7.29); and the lack of understanding 
by healthcare providers of the training and skill sets of pharmacists (73.7%, C.I. ±7.25) as 
barriers. Conversely, the majority of respondents did not accept that language barriers 
(53.5%, C.I. ±8.13) and safety concerns of patients (51.1%, C.I. ±8.12) were barriers to 
enhancing the public health role of community pharmacists. 
 
In addition to the quantitative responses, the questionnaire also provided an option for the 
respondents to supply, in a free text format, comments about what they considered as 
barriers to enhancing the public health role of community pharmacists. The barriers that 
were highlighted varied and included issues such as funding challenges, time pressure, 
commercial pressure from employers, etc:  
 
Various 
 “Lack of co-ordinated approach by utilising all parties; lack of understanding and 
 acceptance of health promotion before treatment; as well as ring-fenced funding 
 arrangements” [E390]. 
 
Commercial Pressure 
“Undue pressure to meet targets by pharmacists’ employers, due to their selfish 
 financial gain” [P9]. 
 
Follow up  
"Follow up is difficult to find out why a patient hasn’t continued, e.g. NRT. Time 
constraints to phone each individual patient who hasn’t returned” [E454]. 
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Conflict of interest 
“GP and GP practices don’t want pharmacies in their team – conflict of interest” 
[B37].  
 
“GPs think we are taking money from them by providing a service” [RC185]. 
Publicity 
“Government/NHS should emphasise pharmacists’ roles more publicly – ever-likely 
as mandatory for those using NHS services regularly, e.g. mandatory MUR for all on 
long-term medications” [P133]. 
 
Underutilised  
“Pharmacist skill set is heavily underutilised” [PR100]. 
 
Commercialism  
“Get rid of target-driven services” [P103]. 
 
In the case of three other respondents, engagement was seen as a solution to eliminate 
some of the barriers: 
 
 “Pharmacists need to be more pro-active” (P8) 
 
 “Inform the public, e.g., A + B to be taken at regular intervals specified on 
 prescription, every 8 hourly, 6 hourly. A + B resistance...” [PR19]. 
 
 “Engagement with NHS England” (P79)  
 
Three other respondents also highlighted the need for capacity development within the 
work force: 
 “Time (&) skills” [RB144]. 
“Direct funding to pharmacists and autonomy” [P112]. 
“On job training with pay benefits” [P147].  
 
According to four respondents, ensuring consistency in service delivery across sectors 
and/or locations can also help to tackle some of the identified barriers:  
“All training should be the same regardless of location, so all extra training can be 
used anywhere in the country” [P103]. 
 
6 
 
“Firstly, pharmacists themselves need to quantify and specify what they're able to do 
for the public and patients rather than just taking on what GPs don't want to do 
anymore for no more money” [E382]. 
 
On the other hand, ten of the respondents highlighted the need for collaboration between 
healthcare professionals, as well as with government bodies. For some, this will also mean 
GPs delegating certain services to pharmacists, various healthcare professionals seeing 
pharmacists more as colleagues, rather than as competitors, as well as recognising each 
others’ roles and abilities. Some of these comments are included below:    
 
“Make medical students aware of (the) need to work together for (the) common 
good of patients at student level” [PR04]. 
d understand (that) pharmacists are part of (the) team, not competitors” [B86 
“Training GPs, etc., and pharmacists together. All groups need to be aware of skills of 
other. Time – there’s a lot to do already!” [RE336].  
“Better working relationship [R 
Two of the respondents would, however, like pharmacies to employ more than one 
pharmacist in a pharmacy, which will, for example, allow pharmacists’ roles to be split 
between dispensing activities and clinical (and public health) activities:   
“Have two pharmacists on duty at all times, (one) dispensing (and the other) clinical. 
Make it law, so pharmacy chains are forced into doing this” [B63]. 
 
“More pharmacists per branch” [RE406]. 
 
Yet according to another two respondents, the delegation of pharmacists’ roles to other 
health teams might be the way forward: 
“Allow dispensers to take the pressure off pharmacists, so they take more 
responsibility for dispensing scripts and pharmacists can concentrate more on other 
services” [RE 372].  
 
“Cut down on pharmacy schools and phase out the need for pharmacists and let 
nurses, doctors and dispensers run local dispensaries” [P12] 
 
In addition, another area of emphasis for many of the respondents was on improving 
funding for community pharmacy public health activities, which eleven of them identified as 
a barrier to enhancing the role of pharmacists in public health.  
 
“More resources and training provided. GPs get paid for such services. We should 
too!” [P149]. 
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“More funding for public health services. More incentives for pharmacists carrying 
out services rather than company targets” [P97].   
. Remove services from GPs that they are underperforming in providing” [RC1 
At the same time, there were several and wide-ranging suggestions for more support and 
training for pharmacists (twenty respondents); enhancing awareness of the services that 
community pharmacists were providing (eighteen respondents); community pharmacists 
becoming more proactive with public health; improving communication between healthcare 
professionals; tackling the undervaluing of pharmacists, as well as reducing community 
pharmacists’ workload. Some of these comments are reported below:   
 
Support and training 
 
“The introduction of protected learning time such as how GPs currently allowed to 
close the practice once a month for 2 hours to allow for training” [UK32] 
 
“Integrating into undergraduate training/provide training in community pharmacy 
post qualification…so it becomes more commonplace training…structure…similar to 
in hospital setting, maybe? Increase public awareness by public campaign” [P11]. 
 
 
Awareness 
 
“Local Pharmaceutical Committees [LPCs] communicate with fund-holders, e.g., 
Public Health England, CAN, Clinical Commissioning Groups [CCGs], etc, and actively 
promote community pharmacy. National bodies, e.g., Pharmaceutical Services 
Negotiating Committee [PSNC] to negotiate more national services” [PR28]. 
 
“Other healthcare professionals to be educated in role of pharmacist. More freedom 
given to pharmacists when consulting patients, e.g. a formulary similar to a nurse” 
[PR54]. 
 
 
Proactive with public health activities 
 
 
“Pharmacists need to understand the bigger picture and must be proactive in 
promoting the services – public health” [Respondent B121]. 
 
“An ‘ask your pharmacist’ campaign on Facebook, buses and newspapers” [C257]. 
 
Communication 
 
“Better communication between healthcare professionals. Training together with 
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other healthcare professionals” [RC191].  
 
“Better communication and understanding of the skill set of pharmacists” [RB148]. 
 
 
 
However, when the questionnaire asked community pharmacists about how essential it was 
that patients get public health services from community pharmacies, some 50% of the 
respondents (C.I. ±8.15) indicated that this was ‘very essential’; some 26.4% indicated 
‘essential’ (C.I. ±7.18); 14.6% indicated ‘quite essential’ (C.I. ±5.76); 8.3% said, ‘sometimes’ 
(C.I. ±4.5), while one respondent (0.7%, C.I. ±1.62) disagreed. On the negative aspects of the 
public health services from community pharmacies and how they could be improved, some 
of the feedback also included that pharmacists were devalued; problems of commercial 
pressure from employers; lack of training; funding challenges; lack of privacy and premises 
arrangement; distractions and lack of commitment from community pharmacists; lack of 
awareness (fourteen respondents); lack of time (twenty-two respondents); workload and 
unmanageable stress levels (ten respondents); inconsistency in service delivery; as well as 
the issue of isolation.  
 
Various 
“Time and resources. If we were given funding for one person to do public health 
services, then we would help patients” [P149]. 
 
“Lack of support to carry out further clinical roles and over-step by pharmaceutical 
companies causing pharmacists to lose their identity in the sector” [PR91].  
 
Devalued 
 
“Considered as shopkeepers” [P79].  
 
“Pharmacists hand out medicines and that is all they do” [P12].  
 
 
Lack of training 
 
“Lack of training for MCAs (Multi-compartment Compliance Aids)” [P81]. 
 
“Lack of training. Non-regular pharmacists” [RC196]. 
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Funding 
 
 “Indifference on the part of pharmacists due to lack of funding” [P137]. 
 
“Too many free items and services available. Many people just take advantage of 
that without any real improvement” [RE354].   
 
 
Premises 
 
“Small space and little time. Second pharmacist (is needed)” [RE406]. 
 
“Premises – need improving” [P49]. 
 
 
Distraction/Lack of commitment  
 
“Pharmacist(s) too bogged down with dispensing and not focused on the other 
services” [B121]. 
 
“People can easily abuse the system – visit multiple pharmacies for free services. 
There should be an electronic registration in place like Scottish Electronic Minor 
Ailments System (eMAS)” [E454]. 
 
 
Lack of awareness  
 
“Public awareness of services offered – more publicity and campaigns. Premises – 
some premises are not fit for purpose. Standards need to be raised so that delivery 
of services would convey professionalism” [P118].   
 
“Archaic mentality of what pharmacists do” [C255].  
 
 
“Negative connotation, due to association with ‘commerce’, that is, ‘just a 
shopkeeper’ [B30].”  
 
 
Lack of time 
 
“Juggling between essential, advanced and enhanced services” [P23]. 
 
 “Lack of time means services are done half-heartedly” [RC244].  
 
 
Workload/stress 
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“Extra workload on top of overcrowded daily work” [C198]. 
 
“Workload of pharmacists is dangerously high, so potential issues with more work” 
[C239]. 
 
 
Inconsistency 
 
“Inconsistent – national programs should be developed” [B109]. 
 
“Companies that own pharmacies should not be involved in activities which show 
conflict of interest, e.g. selling cigarettes” [B123].  
 
Isolation 
 
“No mechanism for sharing with other members (of the healthcare profession) what 
we have done” [C264]. 
 
 
Interestingly, some eighty-six percent of the respondents (C.I., ±5.83) also agreed with the 
statement that ‘the public health role of community pharmacists in the UK is still 
undeveloped in the 21st century'. For the respondents that said ‘yes’ to this question, some 
of the reasons they gave were about the quality of the services provided by community 
pharmacies, hence, the problem of trust; lack of consistency in service delivery; lack of time 
to deliver public health services; community pharmacists not feeling professionally 
empowered enough to provide public health services; lack of training; lack of awareness; 
difficulty adapting to changing needs; feeling undervalued and unrecognised; and lack of 
focus. Yet some of the respondents talked about the accessibility of community pharmacy 
practices. 
 
Quality/trust 
 
“Not enough quality service offered by majority of community pharmacies” [P97] 
 
“Public do not see pharmacy as place to go for public health issues” [PR43]  
 
 
Inconsistency 
 
“Too much variation between areas, doesn’t allow us to build continuity of service” 
[B115]. 
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“People still visit their GP for minor ailments. One reason for this could be because 
prescriptions are free in Wales” [C257]. 
 
 
Lack of time 
 
“We have a lot of experience and knowledge, but not the time to provide the 
services” [RC244]. 
 
“So much more can be done, but time and funding can be a barrier” [P21] 
 
 
Empowerment 
 
“Increase in pharmacists’ powers needed to better contribute to public health – 
greater access to public records, plus information” [P133]. 
 
“More freedom in terms of prescribing” [P130].  
 
 
Training 
 
“(Pharmacists) too overqualified for their present roles” [P17]. 
 
"We are expected to provide a service without specific teaching or training - all we 
do is learning on our own or through one's own experiences" [E382].  
 
 
Awareness 
 
“Pharmacists can do a lot more to contribute to public health. Our biggest hurdle is 
educating the public that we are the first point of call and recognised by NHS” 
[RB27]. 
 
 
 
Adaptation 
 
“Pharmacist(s) are not adapting to the changing needs of this service. Pharmacist(s) 
{are} really placed to provide public health services” [B121]. 
 
“Less checking of prescriptions and more time to counsel” [RE385] 
 
 
Access 
 
“Pharmacists and staff have direct contact with patients, so they can talk to them. 
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Community pharmacists have known patient base, which makes it easier for them to 
approach the patients for health issues” [P110]. 
 
“Easy access for the public” [RB144]. 
 
 
Undervalued/lack of recognition 
 
“So much knowledge gone to waste” [RC162].  
 
“Shopkeeper, not seen as a professional person” [B86]. 
 
“Massive, trained workforce, (but, are) criminally underused and unpaid” [B30]. 
 
 
 
Focus 
 
“Yes, pharmacy could do more, but can’t do everything” [C169]. 
 
“There is still too much focus on high volume dispensing” [E347]. 
 
 
Tests for significance and correlation of variables 
 
Tests for significance indicated that the male respondents (median = 5.0) were more likely 
than the female respondents (median = 4.0) to agree that 'insufficient funding from the 
government' was a barrier to enhancing the public health role of community pharmacists (p 
= .006; Eta, η2 = .053). Regarding a ‘language barrier’, those aged between 70-79 (median = 
1.0) were less likely than other respondents to see this as a barrier (p = .046; η2 = .078; Total 
median = 2.0). Yet those respondents who described themselves as 'pharmacy contractors' 
(median = 4.5), 'other' (median = 5.0) and 'superintendent pharmacists' (median = 5.0) were 
more likely than other respondents to agree that ‘insufficient funding from the government’ 
was a barrier (p = .049; η2 = .096; Total median = 4.0). 
 
In terms of the correlation of variables (Pearson's coefficient, ρ), our male respondents were 
more likely than our female respondents to agree that the lack of support from public 
health practitioners was a barrier to enhancing the public health role of community 
pharmacists [ρ = -.195; p = .020]. Also, there were negative correlations between the 'age of 
respondents' and their likelihood of agreeing that difficulties in recruiting patients [ρ = -
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.168; p = .043]; high dropout rates for public health services [ρ = -.179; p = .031]; low success 
rates for public health services [ρ = -.215; p = .010]; and safety concerns among pharmacists 
[ρ = -.181; p = .030] were barriers to enhancing the public health role of community 
pharmacists. There was also a negative correlation between the 'age of respondents' and 
respondents agreeing that pharmacists should develop their own expertise in public health 
[ρ = -.185; p = .029]. 
 
In terms of location, respondents from Bedfordshire were more likely than respondents 
from Cardiff, Edinburgh and Barnet (in that order) to agree that 'lack of support from public 
health practitioners' was a barrier in enhancing the public health role of community 
pharmacists [ρ = .195; p = .021].  In the same order, respondents from Bedfordshire were 
more likely to also agree that 'lack of patients' records' was a barrier [ρ = .179; p = .033].  
 
 
Discussion 
This survey has confirmed many of the barriers identified elsewhere.4,10 Notably, there is a 
need to address many of the identified barriers hindering the public health role of 
community pharmacists in the UK, such as the community pharmacy environment, which 
sometimes may not be suitable for the delivery of public health services;21 the negative 
perceptions by both the general public and other health providers of pharmacists’ 
competencies; privacy and confidentiality in pharmacies; as well as time pressure and a high 
dispensing workload.  
 
Still, there also seems to be a need to address issues such as the UK healthcare system and 
its policies towards the public health role of the pharmacist, inadequate training of 
pharmacists in public health, lack of documentation of activities and inadequate financial 
support.4,10,16,22 The need for better funding demands closer attention, particularly when 
you also consider that the male respondents were, on the average, less happy with the 
present funding arrangements (p = .006; η2 = .053) than the female respondents. To 
encourage younger pharmacists to participate in public health services, direct remuneration 
to pharmacists might be a game changer (p = .043; η2 = .078). Yet it seems reasonable that 
policy makers and other stakeholders should also be aware of the differences that existed in 
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the responses (based on the role of the respondent) that ‘insufficient funding from the 
government’ was a barrier to enhancing the public health role of community pharmacists (p 
= .049; η2 = .096). 
 
There is also a need to tackle other barriers, which include the lack of professional 
autonomy for pharmacists,21 the lack of input from public health practitioners, the lack of 
support from GPs and public health practitioners, difficulty in communicating with other 
public health providers, the lack of patients’ records, and the lack of understanding by the 
public and healthcare providers of the training and skill sets of pharmacists. In addition, it 
seems necessary to minimise commercial pressures from employers, difficulties in following 
up with patients, the conflict of interest that seems to exist between pharmacists and GPs, 
as well as the underutilisation of pharmacists' skills. Nevertheless, as suggested by some of 
the respondents, it is possible to resolve many of the barriers by, for example, getting rid of 
target-driven services, opening up channels of engagement between pharmacists and 
stakeholders, reducing professional isolation, ensuring consistency in service delivery across 
sectors and localities, enhancing collaboration between community pharmacists and other 
healthcare providers, and ensuring that more than one pharmacist works in community 
pharmacies at any time, as seen in Italy. In addition, role delegation between pharmacists 
and other healthcare professionals and pharmacy support staff will also be necessary. Yet 
there is also a need for pharmacists themselves to be more proactive, assertive and 
committed to public health activities.    
 
Other challenges faced by community pharmacists in their aspiration to provide public 
health services relate to the lack of a well-defined career structure and clear progression 
channels, an unacceptable work-life balance,23 the unavailability of individually contracted 
community pharmacists,24 and the declining ownership of community pharmacies by 
pharmacists.22,25 The conflict of interest which one of our respondents raised as a barrier to 
enhancing the public health role of community pharmacists in the UK, i.e. “GP and GP 
practices don’t want pharmacies in their team – conflict of interest” [B37], could be 
managed by encouraging GP practices to employ more pharmacists as recently proposed by 
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the Royal Pharmaceutical Society (RPS) and the Royal College of General Practitioners 
(RCGP).26 According to a recent publication,27 closer ties with general practice - and primary, 
secondary, tertiary, mental health and social care – are essential to improve the 
contribution of pharmacists to patient care and to secure better prospects for the 
profession.  
 
Not surprising, the underutilisation of pharmacists has often been described as a huge 
waste of resources, as well as a drain on the intellectual skills of pharmacists,24 particularly 
in recent times, when other healthcare professionals are struggling to cope with demands 
which could easily be managed by pharmacists. From some of the comments in this study, it 
was obvious that UK community pharmacists would like the underutilisation of pharmacists 
to be reversed. Yet to address some of these challenges, the profession might also need to 
consider a recent proposal to separate the dispensing role of pharmacists from the 
pharmacy/public health services role,28 while at the same time, promoting the 
establishment of healthy living pharmacies in the UK.29  
 
Supporting the notion that there is a variation in the relationships between GPs and 
community pharmacists across the UK is the revelation that respondents from Edinburgh 
(median = 3.0) were less likely than other respondents to agree that ‘lack of support from 
GPs’ was a barrier to enhancing the role of community pharmacists in public health (p < 
.001; η2 = .157; Total median = 4.0). This variation might need to be investigated further and 
then managed. While the majority of survey respondents felt that the lack of patients' 
records (78.6%, C.I. ±6.66) was a barrier to enhancing the public health role of the 
community pharmacist, a much lower number of respondents (52.1%, C.I. ±8.14) identified 
the lack of documentation of public health interventions as a barrier to enhancing this role. 
For some time, a UK professional association has advocated that community pharmacists be 
given access to patients’ Summary Care Records.30,31 According to the professional 
association, the availability of ‘Summary Care’ records will allow the application of highly 
developed clinical skills that only a pharmacist can perform.31  
 
The recent announcement that SCR access will soon be rolled out to community 
pharmacists across England is not only an encouraging development,32 but will hopefully 
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help to enhance both the clinical, as well as the public health skills of pharmacists. Despite 
the benefits, it has, however, been noted that access to Summary Care health records is not 
risk free, particularly as it may not only increase the risk of prosecution, but could also 
increase the risk of civil claims for any injury caused by a dispensing error in some 
circumstances.33  
 
Recommendation for further studies 
This study identified a number of significant differences and correlations between variables, 
particularly in terms of gender, the role of the respondents and the location of practice. 
Further research in these areas might be needed to identify how tackling these differences 
could help to enhance the public health role of community pharmacists in the UK. 
 
Limitations  
The response rate for this study was very low. However, its impact on the generalisability of 
the results was minimised by the relatively large sample size used in the study and the 
study’s reporting of free text comments, as well as confidence intervals (C.I.), in the results. 
A low response rate is, however, not uncommon for health surveys.34-36 The main 
contributing factor to the low response rate might have been the length of the survey 
questionnaire (which listed sixty-three items, including free text options). Again, the fact 
that the researchers did not have multiple contacts for the respondents or offer any 
financial incentives also might have affected the survey response rate negatively.37 Still, it is 
possible that the poor response rate recorded in this study could be a reflection of how 
disengaged UK community pharmacists are with the profession.38,39 
 
 
Conclusions 
There are numerous opportunities for community pharmacists in public health.10,40-42 
However, several barriers associated with the public health role of community pharmacists 
have been identified as hindering the enhancement of this role; one of them is that the UK’s 
community pharmacy public health practice is still operating at a basic level.1,2,4 Although 
the pharmacy profession is gradually evolving from product-oriented to patient-centred 
care, with pharmacists now contributing to micro-level public health activities, there 
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continues to be an unmet need for UK pharmacists in macro-level public health functions.43 
To achieve this desired objective, both in the UK and globally, it will be necessary to 
enhance, among other things, both the undergraduate and the post-graduate public health 
(including clinical pharmacy)44 training and skills of pharmacists, as well as the career 
structure of community pharmacists. In addition, it will be necessary to enable the 
development of a mixed market in community pharmacy practice by encouraging more 
pharmacists to be employed in GP practices, as well as for the government to contract 
public health services directly to individual or group pharmacists, who are not constrained 
by the burden of the dispensing role. Yet pharmacists should also be encouraged to use 
newer technologies,44 including social media, to enhance their public health practice. 
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Figure 1: Age of participants 
 
 
 Figure 2: Respondent's role in pharmacy  
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Table 1: Barriers to enhancing the public health role of community pharmacists (n = 147). 
 
Responses Disagree 
(%) 
Strongly 
disagree 
(%) 
Neither 
agree 
nor 
disagree 
(%) 
Agree 
(%) 
Strongly 
agree 
(%) 
Insufficient training of pharmacists in PH? (n = 146) 11.0 4.8 17.8 51.4 15.1 
Insufficient skill of pharmacists in PH? (n = 146) 17.1 11.6 21.9 41.1 8.2 
Lack of professional autonomy for pharmacists? (n = 145) 8.3 2.8 22.1 42.8 24.1 
Difficulties in recruiting patients? (n = 145) 13.8 6.9 20.0 42.8 16.6 
Lack of demand for public health services? (n = 145) 28.3 18.6 27.6 20.0 5.5 
High drop rates for public health services? (n = 145) 11.0 9.0 35.9 32.4 11.7 
Low success rates for public health services? (n = 144) 25.0 13.2 31.3 24.3 6.3 
Lack of input from public health practitioners? (n = 145) 6.2 2.1 22.8 50.3 18.6 
Lack of support from public health practitioners? (n = 143) 8.4 1.4 21.0 47.6 21.7 
Difficulty in communicating with other PH providers? (n = 144) 11.1 3.5 16.0 55.6 13.9 
Lack of support from GPs? (n = 145) 7.6 2.8 21.4 37.9 30.3 
Insufficient funding from the government? (n = 145) 8.3 2.1 14.5 33.8 41.4 
Difficulty in fee collection? (n = 145) 15.2 6.2 29.7 34.5 14.5 
Time pressure and workload? (n = 145) 2.1 2.8 5.5 35.2 54.5 
Safety concerns among pharmacists? (n = 145) 13.1 8.3 29.7 33.1 15.9 
Safety concerns by GPs? (n = 145) 20.7 12.4 37.2 20.7 9.0 
Safety concerns of patients? (n = 145) 35.2 15.9 30.3 15.2 3.4 
Lack of patients' records? (n = 145) 4.8 4.8 11.7 46.2 32.4 
Lack of documentation of interventions? (n = 144) 11.1 6.3 30.6 39.6 12.5 
Physical design of community pharmacies? (n = 145) 22.8 6.9 31.7 24.1 14.5 
Misperception that counselling is not needed? (n = 145) 20.0 9.7 22.1 30.3 17.9 
Lack of instrumentation? (n = 145) 11.7 5.5 26.9 48.3 7.6 
Language barrier? (n = 144) 37.5 16.0 27.8 12.5 6.3 
Lack of understanding by the public? (n = 143) 7.0 5.6 14.7 51.0 21.7 
Lack of understanding by HC providers? (n = 141) 7.1 3.5 15.6 54.6 19.1 
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